Cognit AI

Cognit AI is a private genomics-focused AI company developing foundational models to simulate gene regulatory networks and support functional genomics research. The company describes its core technology as a Large Genomic Model intended to enable closed-loop, in-silico gene expression analysis and gene/cell engineering. Its stated areas of work include phenotype prediction from genotype, biomarker discovery, episomal gene synthesis, and ex-vivo and in-vivo design strategies. Cognit AI appears to be at an early research stage rather than a clinical-stage therapeutic developer, with its platform positioned to accelerate drug discovery and precision medicine workflows.